GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 Billion …
2 days ago · Wednesday, GSK Plc (NYSE:GSK) reported fourth-quarter sales of $10.40 billion (8.12 billion Sterling Pounds), up 1% year-over-year and up 4% on constant currency. The …
OFF
GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 Billion …
2 weeks from now
2 days ago · Wednesday, GSK Plc (NYSE:GSK) reported fourth-quarter sales of $10.40 billion (8.12 billion Sterling Pounds), up 1% year-over-year and up 4% on constant currency. The …
yahoo.com
OFF
Full-year And Fourth Quarter 2024 - GSK
2 weeks from now
• Total operating profit -33% and Total EPS -40% largely driven by £1.8 billion ($2.3 billion) charge relating to ... Core earnings will be higher than Total earnings. GSK has undertaken a …
gsk.com
OFF
GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 Billion …
2 weeks from now
3 days ago · GSK's Q4 sales hit $10.40 billion, topping estimates. Specialty Medicines grew 14%, while vaccines declined. The company announced a $2.5 billion share buyback plan.
benzinga.com
OFF
GSK Launches $2.5 Billion Buyback, Lifts Sales Target After Stellar ...
2 weeks from now
2 days ago · GSK's Q4 EPS and sales beat estimates Shares jump 6% R&D investment to focus on speciality medicines Feb 5 (Reuters) - GSK (GSK.L), opens new tab launched a 2 billion …
reuters.com
OFF
GSK Surges 8% After Bumping Its 2031 Outlook To North Of $50 …
2 weeks from now
2 days ago · GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 Billion Stock Buyback, Raises Long-Term Annual Sales Forecast To Over $50 Billion ... (NYSE:GSK) reported fourth …
yahoo.com
OFF
GSK Beats On Q4 Earnings & Sales, Stock Up On Raised Long-Term …
2 weeks from now
2 days ago · GSK reports better-than-expected Q4 earnings. It also announces a new share buyback program and raises the long-term sales outlook for 2031 by $2 billion. ... fourth …
nasdaq.com
OFF
GSK Stock Jumps On Long-Term Outlook Boost, $2.5B Share …
2 weeks from now
2 days ago · Its 23.2 pence ($0.29) core earnings per share (EPS) for the fourth quarter and revenue of 8.12 billion pounds also beat estimates. GSK's U.S.-listed shares were up around …
investopedia.com
OFF
GSK Lags Q4 Earnings, Tops Sales, Issues Upbeat '24 Guidance
2 weeks from now
Jan 31, 2024 · In the last reported quarter, Anavex’s earnings beat estimates by 25.00%. Just Released: Zacks Top 10 Stocks for 2024 Hurry – you can still get in early on our 10 top tickers …
nasdaq.com
OFF
GSK (GSK) Tops Q4 Earnings And Revenue Estimates
2 weeks from now
3 days ago · The current consensus EPS estimate is $1.11 on $9.67 billion in revenues for the coming quarter and $4.07 on $40.5 billion in revenues for the current fiscal year.
zacks.com
OFF
GSK Launches $2.5 Bln Buyback, Lifts Sales Target After Stellar Q4
2 weeks from now
2 days ago · GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, betting that growing sales of its HIV and …
indiatimes.com
OFF
GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 Billion …
2 weeks from now
3 days ago · GSK's Q4 sales hit $10.40 billion, topping estimates. Specialty Medicines grew 14%, while vaccines declined. The company announced a $2.5 billion share buyback plan. ... GSK …
benzinga.com
OFF
GSK (GSK) Q4 Earnings And Revenues Top Estimates - Yahoo Finance
2 weeks from now
Feb 1, 2023 · Glaxo (GSK) delivered earnings and revenue surprises of 8.47% and 4.31%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies …
yahoo.com
OFF
GSK (GSK) Tops Q4 Earnings And Revenue Estimates - MSN
2 weeks from now
GSK (GSK) Tops Q4 Earnings and Revenue Estimates ... The current consensus EPS estimate is $1.11 on $9.67 billion in revenues for the coming quarter and $4.07 on $40.5 billion in …
msn.com
OFF
GSK Shares Rise Over 5% After Q4 Results - Investing.com Canada
2 weeks from now
3 days ago · LONDON - On Wednesday, GlaxoSmithKline plc (NYSE: NYSE: GSK) shares gained 5.65% after the pharmaceutical giant reported fourth quarter revenue that beat analyst …
investing.com
OFF
GSK (GSK) Q4 Earnings And Revenues Top Estimates - Nasdaq
2 weeks from now
Feb 1, 2023 · GSK (GSK) Q4 Earnings and Revenues Top Estimates ... The current consensus EPS estimate is $0.89 on $8.39 billion in revenues for the coming quarter and $3.42 on $34.1 …
nasdaq.com
OFF
Regeneron Pharma Q4 Earnings Crush Estimates, Initiates
2 weeks from now
3 days ago · Regeneron beat Q4 estimates with $12.07 EPS and $3.79B in sales. The company announced a dividend, a $3 billion buyback, and continued R&D investments.
benzinga.com
OFF
BSX Q4 Earnings & Revenues Top, Stock Falls On Weak Gross Margin
2 weeks from now
3 days ago · Boston Scientific Corporation (BSX Quick Quote BSX - Free Report) posted fourth-quarter 2024 adjusted earnings per share (EPS) of 70 cents, up 27.3% from the year-ago …
zacks.com
FAQs about GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 Billion … Coupon?
How much did GSK earn in Q1 (quarterly earnings)?
What was GSK's fourth-quarter sales?
How did GSK perform in Q1 2024?
Will GSK buy back 2 billion pounds of shares in 2025?
How much will GSK's earnings grow in the next year?
What is GSK's price-to-earnings ratio?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
